Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis
Journal
Journal of Oral Pathology and Medicine
Journal Volume
30
Journal Issue
10
Pages
618-625
Date Issued
2001
Author(s)
Abstract
Background: Previous studies have shown that the local and systemic upregulation of fibrogenic cytokines and downregulation of antifibrotic cytokine are central to the pathogenesis of oral submucous fibrosis (OSF). The milk from cows immunized with human intestinal bacteria (immune milk) contains an anti-inflammatory component that may suppress the inflammatory reaction and modulate cytokine production. Therefore, it was decided to test whether immune milk may have some beneficial effects on controlling the symptoms and signs in OSF patients. Methods: In this preliminary study, 26 OSF patients who received immune milk treatment (45 g of immune milk powder twice a day) for 3 months and oral habit intervention were included in the experimental group. Another 20 OSF patients who received only oral habit intervention served as the control group. Results: We found that the interincisor distance was significantly improved (?3 mm of the baseline measurement) in 18 of the 26 (69.2%) OSF patients in the experimental group at exit. However, in the control group none of the OSF patients had an increase in interincisor distance greater than 2 mm. In addition, disappearance or significant improvement of symptoms at exit was observed in 80% (16/20) of the patients with intolerance to spicy foods (P<0.001) and 72.2% (13/18) of the patients with xerostomia (P<0.005) in the experimental group, compared with 17.6% (3/17) of the patients with improvement of intolerance to spicy foods and 15.4% (2/13) of the patients with improvement of xerostomia in the control group. Partial regression of concomitant oral leukoplakia or erythroplakia (judged from the size reduction of the lesions) at exit was noted in 71.4% (5/7) of the patients in the experimental group (P<0.05), compared with none (0/5) of the patients with improvement in the control group. Conclusion: We conclude that oral administration of immune milk leads to significant improvements of symptoms and signs in OSF patients.
Subjects
Immune milk; Oral submucous fibrosis (OSF); Treatment
SDGs
Other Subjects
bacterial vaccine; adult; aged; animal; article; behavior therapy; betel nut; cattle; clinical trial; controlled clinical trial; controlled study; drinking behavior; food allergy; human; immunization; immunology; male; middle aged; milk; mouth disease; mouth mucosa; mouth ulcer; pathology; smoking; spice; trismus; xerostomia; Adult; Aged; Alcohol Drinking; Animals; Areca; Bacterial Vaccines; Behavior Therapy; Cattle; Food Hypersensitivity; Humans; Immunization; Male; Middle Aged; Milk; Mouth Mucosa; Oral Submucous Fibrosis; Oral Ulcer; Smoking; Spices; Trismus; Xerostomia
Type
journal article